CIK 0001816590
- Non-accelerated filer
- Smaller reporting company
COMPASS Pathways plc
Sign in to watch- Ticker
- CMPS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +1 716-676-6461
- Business address
- 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESIRE, United Kingdom, WA14 2DT
- Former names
- Compass Rx Ltd.
- 4 Planned sale Director sold 65,886 shares at an average $10.70 ($704,821)
- 4 Planned sale Director sold 65,886 shares at an average $10.70 ($704,821)
- 4 Grant or award Chief Financial Officer acquired 62,718 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Director sold 59,255 shares at an average $10.29 ($609,862)
- 4 Planned sale Director sold 59,255 shares at an average $10.29 ($609,862)
- 4 Planned sale Director sold 85,293 shares at an average $10.58 ($902,124)
- 4 Planned sale Director sold 85,293 shares at an average $10.58 ($902,124)
- 4 Shares withheld for taxes General Counsel & CLO gave up 3,167 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 3,158 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Director gave up 175 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 10,181 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 10,181 shares (to pay taxes)
- 4 Planned sale Director sold 91,911 shares at an average $8.19 ($752,954)
- 4 Planned sale Director sold 91,911 shares at an average $8.19 ($752,954)
- 4 Planned sale Director sold 95,016 shares at an average $8.88 ($843,864)
- 4 Planned sale Director sold 95,016 shares at an average $8.88 ($843,864)
- 4 Planned sale Director sold 8,464 shares at an average $7.81 ($66,146)
Page 4 of 7 · 137 filings